PCOS Diagnosis, No Plan: Erin's Fertility Case Study

By Ramses Syamsa Anom | Clinical Review by Dr. Angela Sinnett, L.Ac

Erin[a], 36, had spent three years watching her body do something nobody could quite explain to her. Her periods, once dependable enough to set a calendar by, started skipping a week, then a month, then disappearing for stretches long enough that she stopped letting herself hope each time she was late. A miscarriage in year two of trying left her with more questions than the one specialist she saw ever answered. Her AMH, the number every fertility conversation seems to orbit around, came back high, the kind of result that usually gets read aloud as reassuring news. Her chart got a single word stapled to it anyway: PCOS. No explanation of what that actually meant for her body. No plan for what to do next. She left that appointment with a printout and a shrug, the same feeling she'd carried out of nearly every appointment before it: relieved to finally have a name for what was happening, and no closer to understanding why it kept happening at all. What actually changed things was not a new drug, a procedure, or a scarier diagnosis. A 200+ biomarker panel found that Erin's progesterone was collapsing right after ovulation, before it ever had a real chance to hold a pregnancy, that her estrogen was clearing down an inflammatory pathway instead of a protective one, that her cortisol wasn't leaving her system on the schedule it was supposed to, and that she was quietly short on three specific nutrients her body needed to run any of that machinery correctly. Four months into a protocol built around those exact findings, in Charleston, South Carolina, Erin took a pregnancy test on her own birthday. It was positive.

The Seed and the Soil

Most of what Erin had been told about her fertility, across three years and more appointments than she could easily count, focused on one thing: the egg. Her AMH, an approximate marker of how many eggs she has left, kept coming back high, and every provider she asked treated that number like the entire conversation. High AMH, in the world of standard fertility care, usually reads as good news, plenty of eggs, plenty of time. What none of those conversations addressed was the environment those eggs, and any embryo that might come from them, would actually have to survive in. Think of it as the difference between a seed and the soil it's planted in. A seed can be perfectly viable and still fail to grow in soil that's inflamed, undernourished, or hormonally unstable. Egg count and egg quality get treated as though they're the whole story because they're the easiest thing to measure with a single blood draw. But conception and, more importantly, a pregnancy that actually holds, depend just as much on the soil: whether progesterone rises enough after ovulation to support implantation, whether the body is clearing estrogen down a pathway that helps rather than inflames, whether cortisol is behaving the way it should across a normal day, whether the raw nutrients that build and regulate hormones are actually present in the bloodstream. Erin's case is a clean illustration of exactly this gap. Her seed count looked fine on paper. Her soil, examined properly for the first time, told a different story entirely, one made up of five separate, correctable findings rather than one catch-all label. This is also why a diagnosis like PCOS can feel so unsatisfying to actually live with. It describes a pattern, irregular ovulation, certain hormonal markers falling outside a typical range, without saying anything about why that pattern exists in a given body. Two women can carry the exact same three-letter diagnosis and have almost nothing in common underneath it: one driven by insulin resistance, another by elevated androgens, another, like Erin, by a post-ovulation hormonal shortfall compounded by an inflammatory clearance pattern and a set of quiet nutrient gaps. Treating the label instead of the underlying biology is how a woman ends up with a printout and no plan.

The Diagnostic Blueprint: What 200+ Biomarkers Actually Uncovered

Standard fertility workups tend to check somewhere around three hormones on a single cycle day and call the picture complete. Strategic Fertility's diagnostic process instead evaluates more than 200 biomarkers across the interconnected systems that actually govern reproductive function, adrenal, hepatic, nutritional, and hormonal alike. For Erin, that broader lens surfaced five distinct findings, each one traced directly back to her own lab work, not assumed or borrowed from a more common presentation. Low post-ovulation progesterone. Ovulation itself was not the primary obstacle. What Erin's panel showed was that progesterone, the hormone responsible for stabilizing the uterine lining and sustaining a pregnancy through its earliest, most fragile weeks, was not rising to the level it needed to reach after ovulation occurred. This is a subtler finding than anovulation, and one a standard three-hormone panel run on the wrong cycle day can miss entirely, but it explains a great deal: ovulation without adequate post-ovulation support gives a fertilized egg very little to hold onto. Inflammatory estrogen pathways. Estrogen doesn't just exist in the body, it has to be metabolized and cleared, and it can be cleared down more than one biochemical route. Erin's panel showed her body was routing a disproportionate share of its estrogen down an inflammatory clearance pathway rather than the protective one, a pattern that compounds hormonal imbalance rather than resolving it and can directly interfere with the cycle regularity and uterine environment a pregnancy depends on. Poor cortisol clearance. Cortisol is supposed to follow a rhythm across the day, high in the morning, tapering by evening, and it's also supposed to leave the body on a reasonable schedule once its job is done. Erin's panel showed cortisol clearing too slowly, leaving elevated stress hormone circulating longer than it should. Because cortisol and progesterone are built from shared biochemical building blocks, a body working overtime to manage cortisol has less raw material left over to build the progesterone a pregnancy needs. B12, folate, and biotin deficiencies. All three of these nutrients function as cofactors, meaning the body's hormonal and detoxification pathways cannot run efficiently without them present in adequate amounts. Erin was low across all three simultaneously, a combination that touches methylation, red blood cell formation, and the liver's capacity to clear hormones properly, three processes that sit directly upstream of everything listed above. Low omega-3 fatty acids. Omega-3s are a primary raw material the body uses to build anti-inflammatory signaling molecules. With Erin's levels running low, her body had a reduced capacity to counterbalance the inflammatory estrogen clearance pattern already identified above, one finding actively reinforcing another rather than existing in isolation. None of these five findings would have shown up on the standard panel Erin had already been given more than once. Each one is a specific, measurable, correctable piece of her own biology, not a generic wellness theory applied to her case after the fact. If you're staring at a PCOS diagnosis with no real explanation of what it means for your specific body, Dr. Angela Sinnett walks through exactly this kind of case, root cause by root cause, in a free masterclass. Watch it here.

The Four-Step Protocol, and What Changed

Erin's custom protocol was built directly against the five findings above, not against the word PCOS sitting alone on a chart. It broke down into four coordinated steps. Step one: post-ovulatory progesterone support. Targeted support was introduced specifically for the window after ovulation, giving her body the hormonal follow-through it had been missing, rather than only focusing on whether ovulation itself was occurring. Step two: optimizing estrogen clearance. Nutritional and botanical support was introduced to help shift Erin's estrogen metabolism away from the inflammatory pathway her panel had identified and toward the protective one, addressing the pattern rather than just its downstream symptoms. Step three: B-vitamin repletion. A targeted, bioavailable B12, folate, and biotin protocol was built to close the specific gaps her panel had surfaced, restoring the cofactors her methylation and hormone-clearance pathways needed to function. Step four: anti-inflammatory fatty acid support. A therapeutic omega-3 protocol was introduced to rebuild her body's anti-inflammatory capacity and directly support the estrogen-clearance work already underway in step two. Within weeks of starting the protocol, Erin noticed her cycle doing something it hadn't done in a long time: arriving roughly on schedule. It was a small thing to describe out loud, and it was the first sign, and it mattered on its own, a concrete signal that her post-ovulation hormonal picture was shifting in the direction the protocol was built to move it. It is worth pausing here to say plainly: this protocol worked because it was built for Erin's own biology, not because progesterone support or B-vitamin repletion is a universal fix for every PCOS diagnosis. Another patient with the same three letters on her chart could have an entirely different root cause, elevated androgens, insulin resistance, a different estrogen clearance pattern, and would need an entirely different protocol built around her own 200+ biomarker findings. What worked for Erin is specific to her. The real proof, though, would take longer to arrive, through a cycle Erin had stopped letting herself get her hopes up about after the miscarriage two years earlier. Four months into her protocol, on her own birthday, Erin took a pregnancy test. It was positive.

Clinical Checklist: 5 Diagnostic Questions to Ask Before Another Procedure

* Has anyone actually tested my post-ovulation progesterone level, not just confirmed that ovulation happened?

* Which estrogen clearance pathway is my body actually using, and has that ever been measured?

* Has my cortisol been evaluated across a full daily rhythm, not just as a single isolated number?

* Have my B12, folate, and biotin levels been checked directly, rather than assumed adequate from a multivitamin?

* If I was handed a diagnosis like PCOS, was I ever given a specific explanation of what it means for my own biology, or just the label itself?

Frequently Asked Questions

Can you have PCOS with a high AMH and still have a progesterone problem?

Yes. AMH reflects egg reserve, not what happens hormonally after ovulation. A high AMH result and a post-ovulation progesterone deficiency can and do coexist, and a standard panel focused only on AMH and a general hormone snapshot can miss the progesterone finding entirely.

Why would missing periods and a prior miscarriage both trace back to the same root causes?

Irregular cycles and early pregnancy loss can both stem from the same underlying hormonal instability, in Erin's case a combination of insufficient post-ovulation progesterone, an inflammatory estrogen clearance pattern, and slow cortisol clearance, since all three affect the uterine environment a pregnancy depends on from the very beginning.

Is B12, folate, and biotin repletion something I could just start on my own?

Confirming an actual deficiency through direct testing, and using bioavailable forms dosed to the specific gap found, matters more than supplementing broadly on assumption. A generic multivitamin is not the same as a targeted repletion protocol built against a confirmed lab finding.

How long does a protocol like this typically take to show results?

Every case is different because every root-cause picture is different, but Erin's own early signal, a cycle returning to a regular rhythm, appeared within weeks of starting her protocol, with conception following at four months. Some patients see change sooner, some need longer, depending on what their own biomarkers show.

What makes a 200+ biomarker panel different from what my current doctor already ran?

Most standard fertility workups check a small handful of hormones on a single cycle day. A 200+ biomarker panel evaluates hormonal, adrenal, nutritional, and metabolic systems together, which is what allowed Erin's progesterone, estrogen clearance, cortisol, and nutrient findings to surface as one connected picture instead of four separate, unexplained numbers. If your labs keep coming back "normal" while your body tells you something is still wrong, a $37 Discovery Call is the first step toward finding out what a standard panel never checked. Book your Discovery Call here.